Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall. - Investor's Business Daily

As reported by Investor's Business Daily

Viking stock catapulted Tuesday on "stellar" test results for its weight-loss shot, sending Eli Lilly and Novo down.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Investor's Business Daily ↗

Market Samachar is a news aggregator. This article was originally published by Investor's Business Daily. Tap the button above to read the full story on their site.

INDIAN Multibagger Cupid shares gain 6% after company raises FY27 revenue, profit guidance. Could this trigger a further rally? mint - markets
INDIAN Concord Biotech 1:1 bonus issue announced! Jhunjhunwala family-backed stock up 50% in 6 months— record date, details mint - markets
INDIAN US stock market LIVE updates: Dow Jones opens lower; Xi Jinping US visit, US-Iran news in focus mint - markets
INDIAN Jagsonpal Pharmaceuticals to acquire wellness portfolio of Group Pharmaceuticals Share Market Today
COMPANIES Sebi weighs lower margins for longer-term derivatives as F&O losses stay high: Tuhin Kanta Pandey Stocks-Markets-Economic Times
INDIAN US stocks: US markets opens lower as oil, bond yields move higher Markets-Economic Times
COMPANIES Cupid raises FY27 profit guidance, targets Rs 750 crore revenue; stock up 160% in 2026 Stocks-Markets-Economic Times
CRYPTO ESMA to prioritize EU-wide AI and tokenization supervision in 2027 Cointelegraph.com News

Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall. - Investor's Business Daily

More from Market Samachar